The application of blockchain technology in clinical trials is sparking a lot of interest in the pharmaceutical industry. Blockchain has the potential to be a game changer in the way clinical studies are conducted – opportunities go from streamlining patient recruitment to ensuring patient data security and enhancing data transparency. In this workshop, Manuela and Michaela transpose their expertise in emerging technologies being used in the pharmaceutical sector and address the impact of blockchain in clinical trials, the opportunities and the challenges ahead.
Join this brainstorming discussion to learn more about the potential of blockchain technology within the clinical trial setting.
Key areas to be discussed include:
Workshop Leaders: Manuela Schöner, Corporate Strategy & Consulting, Boehringer Ingelheim & Michaela Kazmaier, IT Benefits Realisation Manager, Dimension Data
Pharma is heavily dependent on finding the right patients for clinical trials to accelerate recruiting and ensure that patients remain compliant throughout the trial – to the end. In oncology this is
especially critical to proving efficacy and ensuring that knowledge is maximized for current treatments and especially future ones. The industry has seen trials delayed and even fail repeatedly due to identifying the wrong patients, as well as not maintaining their interest all the way to completion. This costs pharma companies
a lot of money.
This workshop aims to create a thought-provoking discussion led by David Goren, a pharma veteran and expert in the digital innovation space.
Join this interactive, comprehensive and collaborative session that will allow you to employ innovative digital approaches in clinical programs to improve clinical and financial results.
Key topics to be discussed include:
Workshop Leader: David Goren, Independent Consultant, (former- VP of Digital Health Innovation, AstraZeneca)